{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:50:56Z","timestamp":1781704256566,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study aims to explore the research hotspots and trends of urea cycle disorders through bibliometric analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using the Web of Science Core Collection as the database, we retrieved literature published from 2007 to 2024. We utilized CiteSpace, VOSviewer, and Bibliometrix R package to conduct a bibliometric visualization analysis, including the number of publications, citation frequency, publishing countries, institutions, journals, authors, references, and keywords.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 926 publications on UCDs were published in 318 journals by 4807 authors at 1494 institutions from 49 countries\/regions. The USA had the highest number of publications and citation frequency. The Children\u2019s National Health System in the USA published the most literature. The most frequent collaboration was between the USA and Germany. The journal with the most publications was Molecular Genetics and Metabolism. The author with the most publications was Johannes H\u00e4berle. The most frequently cited reference was the 2019 publication of the revised guidelines for the diagnosis and management of UCDs. The identified future research hotspots are expected to focus on \u201cgene therapy\u201d, \u201cmutations\u201d and \u201cefficacy\u201d.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study is the first bibliometric analysis of publications in the field of UCDs. These findings suggest that European and American countries dominate UCD research, it is necessary to further strengthen global cooperation in the field of UCDs. Early detection of the disease and emerging therapies, including gene therapy, are likely to be future research hotspots.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03625-3","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:48:32Z","timestamp":1741099712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Global research dynamics in urea cycle disorders: a bibliometric study highlighting key players and future directions"],"prefix":"10.1186","volume":"20","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueer","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2627-796X","authenticated-orcid":false,"given":"Binhui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"3625_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/BF01757657","volume":"11","author":"HA Krebs","year":"1932","unstructured":"Krebs HA, Henseleit K. Untersuchungen \u00dcber die Harnstoffbildung Im tierk\u00f6rper. Klin Wochenschr. 1932;11:757\u20139.","journal-title":"Klin Wochenschr"},{"issue":"7013","key":"3625_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/s0140-6736(58)90666-4","volume":"1","author":"JD Allan","year":"1958","unstructured":"Allan JD, Cusworth DC, Dent CE, et al. A disease, probably hereditary characterized by severe mental deficiency and a constant gross abnormality of aminoacid metabolism. Lancet. 1958;1(7013):182\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(58)90666-4.","journal-title":"Lancet"},{"issue":"11","key":"3625_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3760\/cma.j.cn112140-20220412-00319","volume":"60","author":"Committee of Clinical Biochemical Genetics, Branch of Medical Genetic Physician, Chinese Medical Doctor Association","year":"2022","unstructured":"Committee of Clinical Biochemical Genetics, Branch of Medical Genetic Physician, Chinese Medical Doctor Association. Subspecialty group of endocrinologic, hereditary and metabolic diseases, the society of pediatrics, Chinese medical association; division of genetics and metabolomics child diseases and health care branch, Chinese association for maternal and child health; division of biochemistry and metabolism, medical genetics branch, Chinese medical association; China alliance of rare disease. Guidelines for diagnosis, treatment and management of Urea cycle disorders in China. Zhonghua Er Ke Za Zhi. 2022;60(11):1118\u201326. https:\/\/doi.org\/10.3760\/cma.j.cn112140-20220412-00319. Chinese.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"3625_CR4","doi-asserted-by":"publisher","unstructured":"H\u00e4berle J, Siri B, Dionisi-Vici C. Quo vadis ureagenesis disorders? A journey from 90 years ago into the future. J Inherit Metab Dis 2024 Jun 4. https:\/\/doi.org\/10.1002\/jimd.12763","DOI":"10.1002\/jimd.12763"},{"key":"3625_CR5","doi-asserted-by":"publisher","unstructured":"Batshaw Ml, Tuchman M, Summar M et al. Members of the Urea cycle disorders consortium. A longitudinal study of Urea cycle disorders. Mol Genet Metab 2014 Sep-Oct;113(1\u20132):127\u201330. https:\/\/doi.org\/10.1016\/j.ymgme.2014.08.001","DOI":"10.1016\/j.ymgme.2014.08.001"},{"issue":"6","key":"3625_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3724\/zdxbyxb-2023-0378","volume":"52","author":"X Huang","year":"2023","unstructured":"Huang X. Treatment and management for children with Urea cycle disorder in chronic stage. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;52(6):744\u201350. https:\/\/doi.org\/10.3724\/zdxbyxb-2023-0378.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"729","key":"3625_CR7","doi-asserted-by":"publisher","first-page":"eadh1334","DOI":"10.1126\/scitranslmed.adh1334","volume":"16","author":"S Gurung","year":"2024","unstructured":"Gurung S, Timmermand Ov, Perocheau D, et al. mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria. Sci Transl Med. 2024;16(729):eadh1334. https:\/\/doi.org\/10.1126\/scitranslmed.adh1334.","journal-title":"Sci Transl Med"},{"key":"3625_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/BF02016680","volume":"12","author":"RN Broadus","year":"1987","unstructured":"Broadus RN. Toward a definition of bibliometrics. Scientometrics. 1987;12:373\u20139. https:\/\/doi.org\/10.1007\/BF02016680.","journal-title":"Scientometrics"},{"issue":"1","key":"3625_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s12672-024-01735-1","volume":"15","author":"Y Fan","year":"2024","unstructured":"Fan Y, Xiao H, Wang Y, Wang S, Sun H. Global research on nanomaterials for liver cancer from 2004 to 2023: a bibliometric and visual analysis. Discov Oncol. 2024;15(1):838. https:\/\/doi.org\/10.1007\/s12672-024-01735-1.","journal-title":"Discov Oncol"},{"key":"3625_CR10","doi-asserted-by":"publisher","first-page":"1488425","DOI":"10.3389\/fgene.2024.1488425","volume":"15","author":"Z Cui","year":"2024","unstructured":"Cui Z, Wang Y, Luo F, Diao J, Yuan B. Mapping the current status and outlook of research on Noonan syndrome over the last 26 years: a bibliometric and visual analysis. Front Genet. 2024;15:1488425. https:\/\/doi.org\/10.3389\/fgene.2024.1488425.","journal-title":"Front Genet"},{"key":"3625_CR11","doi-asserted-by":"publisher","first-page":"697633","DOI":"10.3389\/fpubh.2021.697633","volume":"9","author":"Y You","year":"2021","unstructured":"You Y, Li W, Liu J, et al. Bibliometric review to explore emerging High-Intensity interval training in health promotion: A new century picture. Front Public Health. 2021;9:697633. https:\/\/doi.org\/10.3389\/fpubh.2021.697633.","journal-title":"Front Public Health"},{"issue":"5","key":"3625_CR12","doi-asserted-by":"publisher","first-page":"e7091","DOI":"10.1016\/j.jpurol.2021.08.003","volume":"17","author":"R Matta","year":"2021","unstructured":"Matta R, Schaeffer AJ. The top 100 cited articles in pediatric urology: A bibliometric analysis. J Pediatr Urol. 2021;17(5):e7091\u201370912. https:\/\/doi.org\/10.1016\/j.jpurol.2021.08.003.","journal-title":"J Pediatr Urol"},{"issue":"5","key":"3625_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jpurol.2018.04.004","volume":"14","author":"N Fernandez","year":"2018","unstructured":"Fernandez N, Puerto A, Azuero A, et al. Historical bibliometric analysis of the top cited articles on vesicoureteral reflux 1950\u20132016, and incorporation of a novel impact index. J Pediatr Urol. 2018;14(5):446. e1-446.e9.","journal-title":"J Pediatr Urol"},{"key":"3625_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","volume":"15","author":"M Hole\u010dek","year":"2018","unstructured":"Hole\u010dek M. Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutr Metab (Lond). 2018;15:33. https:\/\/doi.org\/10.1186\/s12986-018-0271-1.","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"3625_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s11192-017-2300-7","volume":"111","author":"NJ van Eck","year":"2017","unstructured":"van Eck NJ, Waltman L. Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics. 2017;111(2):1053\u201370. https:\/\/doi.org\/10.1007\/s11192-017-2300-7.","journal-title":"Scientometrics"},{"issue":"6","key":"3625_CR16","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","volume":"42","author":"J H\u00e4berle","year":"2019","unstructured":"H\u00e4berle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of Urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42(6):1192\u2013230. https:\/\/doi.org\/10.1002\/jimd.12100.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"3625_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/nm0912-1309","volume":"18","author":"K Raven","year":"2012","unstructured":"Raven K. NIH aims to facilitate extramural research through new grants. Nat Med. 2012;18(9):1309. https:\/\/doi.org\/10.1038\/nm0912-1309.","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"3625_CR18","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ymgme.2010.01.017","volume":"100","author":"A Gropman","year":"2010","unstructured":"Gropman A. Brain imaging in Urea cycle disorders. Mol Genet Metab. 2010;100(Suppl 1):S20\u201330. https:\/\/doi.org\/10.1016\/j.ymgme.2010.01.017.","journal-title":"Mol Genet Metab"},{"key":"3625_CR19","doi-asserted-by":"publisher","first-page":"w14587","DOI":"10.4414\/smw.2018.14587","volume":"148","author":"A Amstutz","year":"2018","unstructured":"Amstutz A, Schandelmaier S, Frei R, Surina J, Agarwal A, Alturki R, von Niederh\u00e4usern B, von Elm E, Briel M, On Behalf Of The MAking Randomized Trials Affordable Marta Group. Funding characteristics of randomised clinical trials supported by the Swiss National science foundation: a retrospective cohort study. Swiss Med Wkly. 2018;148:w14587. https:\/\/doi.org\/10.4414\/smw.2018.14587.","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"3625_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/jimd.12807","volume":"47","author":"E Richard","year":"2024","unstructured":"Richard E, Mart\u00ednez-Pizarro A, Desviat LR. Exploring RNA therapeutics for Urea cycle disorders. J Inherit Metab Dis. 2024;47(6):1269\u201377. https:\/\/doi.org\/10.1002\/jimd.12807.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"3625_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0551-7","volume":"12","author":"R Rodriguez-Monguio","year":"2017","unstructured":"Rodriguez-Monguio R, Spargo T, Seoane-Vazquez E. Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients\u2019 health needs? Orphanet J Rare Dis. 2017;12(1):1. https:\/\/doi.org\/10.1186\/s13023-016-0551-7.","journal-title":"Orphanet J Rare Dis"},{"key":"3625_CR22","unstructured":"Senate Brennan J. House Agree to Cut Orphan Drug Research Credit in Half in Tax Bill. Regulatory Focus. December 18, 2017. https:\/\/www.raps.org\/regulatory-focus-\/news-articles\/2017\/12\/senate,-house-agree-to-cut-orphan-drug-research-credit-in-half-in-tax-bill"},{"issue":"1","key":"3625_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13023-023-02915-y","volume":"18","author":"M Xu","year":"2023","unstructured":"Xu M, Li G, Li J, Xiong H, He S. Pharmacovigilance for rare diseases: a bibliometrics and knowledge-map analysis based on web of science. Orphanet J Rare Dis. 2023;18(1):303. https:\/\/doi.org\/10.1186\/s13023-023-02915-y.","journal-title":"Orphanet J Rare Dis"},{"key":"3625_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1172-7-32","volume":"7","author":"J H\u00e4berle","year":"2012","unstructured":"H\u00e4berle J, Boddaert N, Burlina A, et al. Suggested guidelines for the diagnosis and management of Urea cycle disorders. Orphanet J Rare Dis. 2012;7:32. https:\/\/doi.org\/10.1186\/1750-1172-7-32.","journal-title":"Orphanet J Rare Dis"},{"issue":"18","key":"3625_CR25","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa050456","volume":"353","author":"J H\u00e4berle","year":"2005","unstructured":"H\u00e4berle J, G\u00f6rg B, Rutsch F, et al. Congenital glutamine deficiency with glutamine synthetase mutations. N Engl J Med. 2005;353(18):1926\u201333. https:\/\/doi.org\/10.1056\/NEJMoa050456.","journal-title":"N Engl J Med"},{"issue":"10","key":"3625_CR26","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","volume":"24","author":"L Villiger","year":"2018","unstructured":"Villiger L, Grisch-Chan Hm, Lindsay H, et al. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice. Nat Med. 2018;24(10):1519\u201325. https:\/\/doi.org\/10.1038\/s41591-018-0209-1.","journal-title":"Nat Med"},{"issue":"9","key":"3625_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S2213-8587(20)30222-9","volume":"8","author":"J H\u00e4berle","year":"2020","unstructured":"H\u00e4berle J. Suitability of Nitisinone for alkaptonuria. Lancet Diabetes Endocrinol. 2020;8(9):732\u20133. https:\/\/doi.org\/10.1016\/S2213-8587(20)30222-9.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3625_CR28","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1038\/s41598-019-39627-y","volume":"9","author":"T Saheki","year":"2019","unstructured":"Saheki T, Moriyama M, Kuroda E, et al. Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model. Sci Rep. 2019;9(1):4179. https:\/\/doi.org\/10.1038\/s41598-019-39627-y.","journal-title":"Sci Rep"},{"issue":"8","key":"3625_CR29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/biom10081100","volume":"10","author":"T Saheki","year":"2020","unstructured":"Saheki T, Moriyama M, Funahashi A, et al. AGC2 (Citrin) Deficiency-From recognition of the disease till construction of therapeutic procedures. Biomolecules. 2020;10(8):1100. https:\/\/doi.org\/10.3390\/biom10081100.","journal-title":"Biomolecules"},{"issue":"5","key":"3625_CR30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jhep.2008.05.016","volume":"49","author":"M Komatsu","year":"2008","unstructured":"Komatsu M, Yazaki M, Tanaka N, et al. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J Hepatol. 2008;49(5):810\u201320. https:\/\/doi.org\/10.1016\/j.jhep.2008.05.016.","journal-title":"J Hepatol"},{"issue":"5","key":"3625_CR31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jhep.2005.09.018","volume":"44","author":"M Moriyama","year":"2006","unstructured":"Moriyama M, Li MX, Kobayashi K, et al. Pyruvate ameliorates the defect in ureogenesis from ammonia in citrin-deficient mice. J Hepatol. 2006;44(5):930\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2005.09.018.","journal-title":"J Hepatol"},{"key":"3625_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/HMER.S140711","volume":"10","author":"N Savy","year":"2018","unstructured":"Savy N, Brossier D, Brunel-Guitton C, et al. Acute pediatric hyperammonemia: current diagnosis and management strategies. Hepat Med. 2018;10:105\u201315. https:\/\/doi.org\/10.2147\/HMER.S140711.","journal-title":"Hepat Med"},{"issue":"17","key":"3625_CR33","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.3390\/jcm11175045","volume":"11","author":"E Martin-Hernandez","year":"2022","unstructured":"Martin-Hernandez E, Quijada-Fraile P, Correcher P, et al. Switching to glycerol phenylbutyrate in 48 patients with Urea cycle disorders: clinical experience in Spain. J Clin Med. 2022;11(17):5045. https:\/\/doi.org\/10.3390\/jcm11175045.","journal-title":"J Clin Med"},{"issue":"11","key":"3625_CR34","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3760\/cma.j.cn112140-20220412-00319","volume":"60","author":"Committee of Clinical Biochemical Genetics, Branch of Medical Genetic Physician, Chinese Medical Doctor Association","year":"2022","unstructured":"Committee of Clinical Biochemical Genetics, Branch of Medical Genetic Physician, Chinese Medical Doctor Association. Subspecialty group of endocrinologic, hereditary and metabolic diseases, the society of pediatrics, Chinese medical association; division of genetics and metabolomics child diseases and health care branch, Chinese association for maternal and child health; division of biochemistry and metabolism, medical genetics branch, Chinese medical association; China alliance of rare disease. Guidelines for diagnosis, treatment and management of Urea cycle disorders in China. Zhonghua Er Ke Za Zhi. 2022;60(11):1118\u201326. https:\/\/doi.org\/10.3760\/cma.j.cn112140-20220412-00319.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"4","key":"3625_CR35","doi-asserted-by":"publisher","first-page":"101039","DOI":"10.1016\/j.gim.2023.101039","volume":"26","author":"R Posset","year":"2024","unstructured":"Posset R, Garbade Sf, Gleich F, et al. Severity-adjusted evaluation of liver transplantation on health outcomes in Urea cycle disorders. Genet Med. 2024;26(4):101039. https:\/\/doi.org\/10.1016\/j.gim.2023.101039.","journal-title":"Genet Med"},{"issue":"9","key":"3625_CR36","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s10038-019-0614-4","volume":"64","author":"S Matsumoto","year":"2019","unstructured":"Matsumoto S, H\u00e4berle J, Kido J, et al. Urea cycle disorders-update. J Hum Genet. 2019;64(9):833\u201347. https:\/\/doi.org\/10.1038\/s10038-019-0614-4.","journal-title":"J Hum Genet"},{"issue":"1","key":"3625_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/jimd.12609","volume":"47","author":"C DUFF","year":"2024","unstructured":"DUFF C, ALEXANDER IE. Gene therapy for Urea cycle defects: an update from historical perspectives to future prospects. J Inherit Metab Dis. 2024;47(1):50\u201362. https:\/\/doi.org\/10.1002\/jimd.12609.","journal-title":"J Inherit Metab Dis"},{"key":"3625_CR38","unstructured":"Ultragenyx Pharmaceutical Inc. Safety and Dose-Finding study of DTX301 (scAAV8OTC) in adults with Late-Onset ornithine transcarbamylase (OTC) deficiency.Accessed 1st August 2024. https:\/\/clinicaltrials.gov\/search?id=NCT02991144"},{"key":"3625_CR39","unstructured":"Ultragenyx Pharmaceutical Inc. Clinical Study of DTX301 AAV- Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency. Accessed 22 August 2024. https:\/\/clinicaltrials.gov\/search?id=NCT05345171"},{"key":"3625_CR40","unstructured":"University, College. London. Halting Ornithine Transcarbamylase Deficiency with Recombinant AAV in ChildrEn (HORACE). Accessed 1st August 2024. https:\/\/clinicaltrials.gov\/search?id=NCT05092685"},{"key":"3625_CR41","unstructured":"iECURE I. An Open-label study to investigate ECUR-506 in male babies less than 9 months of age with neonatal onset OTC deficiency (OTC-HOPE). Accessed 24 August 2024. https:\/\/clinicaltrials.gov\/search?id=NCT06255782"},{"key":"3625_CR42","unstructured":"Arcturus, Therapeutics. Inc. Study for adolescents and adults with ornithine transcarbamylase deficiency to evaluate safety and tolerability of ARCT-810. Accessed 1st August 2024. https:\/\/clinicaltrials.gov\/search?id=NCT05526066"},{"issue":"9","key":"3625_CR43","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1097\/TP.0000000000002605","volume":"103","author":"F Smets","year":"2019","unstructured":"Smets F, Dobbelaere D, Mckiernan P, et al. Phase I\/II trial of Liver-derived mesenchymal stem cells in pediatric Liver-based metabolic disorders: A prospective, open label, multicenter, partially randomized, safety study of one cycle of heterologous human adult Liver-derived progenitor cells (HepaStem) in Urea cycle disorders and Crigler-Najjar syndrome patients. Transplantation. 2019;103(9):1903\u201315. https:\/\/doi.org\/10.1097\/TP.0000000000002605.","journal-title":"Transplantation"},{"issue":"4","key":"3625_CR44","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/jimd.12343","volume":"44","author":"A Diaz Ga, Schulze","year":"2021","unstructured":"Diaz Ga, Schulze A, Mcnutt M, et al. Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency. J Inherit Metab Dis. 2021;44(4):847\u201356. https:\/\/doi.org\/10.1002\/jimd.12343.","journal-title":"J Inherit Metab Dis"},{"key":"3625_CR45","doi-asserted-by":"publisher","first-page":"1177127","DOI":"10.3389\/fimmu.2023.1177127","volume":"14","author":"Y Su","year":"2023","unstructured":"Su Y, Ruan Z, Li S, et al. Emerging trends and research foci of neuromyelitis Optica spectrum disorder: a 20-year bbliometric analysis. Front Immunol. 2023;14:1177127. https:\/\/doi.org\/10.3389\/fimmu.2023.1177127.","journal-title":"Front Immunol"},{"issue":"1","key":"3625_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/nu16010013","volume":"16","author":"A Burlina","year":"2023","unstructured":"Burlina A, Gasperini S, la Marca G, Pession A, Siri B, Spada M, Ruoppolo M, Tummolo A. Long-Term management of patients with mild Urea cycle disorders identified through the newborn screening: an expert opinion for clinical practice. Nutrients. 2023;16(1):13. https:\/\/doi.org\/10.3390\/nu16010013.","journal-title":"Nutrients"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03625-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03625-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03625-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:48:37Z","timestamp":1741099717000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03625-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3625"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03625-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}